within Pharmacolibrary.Drugs.R_RespiratorySystem.R03D_OtherSystemicDrugsForObstructiveAirwayDiseases.R03DX07_Roflumilast;
model Roflumilast 
   extends Pharmacolibrary.Drugs.ATC.R.R03DX07;

  annotation(Documentation(
    info ="<html><body><p>Roflumilast is a selective phosphodiesterase-4 (PDE4) inhibitor used as an anti-inflammatory drug primarily in the treatment of severe chronic obstructive pulmonary disease (COPD) with a history of exacerbations. It is approved as an oral therapy to reduce the risk of COPD exacerbations.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers after a single oral dose.</p><h4>References</h4><ol><li><p>Han, M, et al., &amp; Li, JT (2023). A Single-center, Open-label, Parallel Control Study Comparing the Pharmacokinetics and Safety of a Single Oral Dose of Roflumilast and Its Active Metabolite Roflumilast N-oxide in Healthy Chinese and Caucasian Volunteers. <i>Clinical pharmacology in drug development</i> 12(3) 314–323. DOI:<a href=&quot;https://doi.org/10.1002/cpdd.1209&quot;>10.1002/cpdd.1209</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36484261/&quot;>https://pubmed.ncbi.nlm.nih.gov/36484261</a></p></li><li><p>Li, Q, et al., &amp; Ding, L (2017). Pharmacokinetics of Roflumilast and Its Active Metabolite Roflumilast N-Oxide in Healthy Chinese Subjects After Single and Multiple Oral Doses. <i>European journal of drug metabolism and pharmacokinetics</i> 42(3) 371–381. DOI:<a href=&quot;https://doi.org/10.1007/s13318-016-0343-4&quot;>10.1007/s13318-016-0343-4</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27306372/&quot;>https://pubmed.ncbi.nlm.nih.gov/27306372</a></p></li><li><p>Mansilla-Polo, M, et al., &amp; Morgado-Carrasco, D (2024). [Translated aticle] Topical and Oral Roflumilast in Dermatology: A Narrative Review. <i>Actas dermo-sifiliograficas</i> 115(3) T265–T279. DOI:<a href=&quot;https://doi.org/10.1016/j.ad.2024.01.009&quot;>10.1016/j.ad.2024.01.009</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38224734/&quot;>https://pubmed.ncbi.nlm.nih.gov/38224734</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Roflumilast;
